13F HOLDINGS REPORT
Kinnevik AB (publ)
Quarter ended Q1 2023 · Filed February 1, 2023 · Accession 0001104659-23-009298
Total Value
$177.3M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Teladoc Health, Inc. | TDOC | 3,683,668 | $87.1M | 49.14% |
| 2 | Recursion Pharmaceuticals, Inc. | RXRX | 7,653,061 | $59.0M | 33.28% |
| 3 | Babylon Holdings Ltd | BABB | 4,617,340 | $31.2M | 17.58% |